Review
Open access
Aug 2026
On the Edge of Benefit and Harm: Reactive Oxygen Species in Cancer
A deeper understanding of tumor-specific redox vulnerabilities will be essential for developing precise and clinically effective ROS-oriented cancer therapies and the need for robust redox biomarkers is highlighted.
A. Nikiforova
· International Journal of Mol... · 1 citation